TheraRadar
← Back
Data updated: Mar 29, 2026

Lupin

CardiovascularInfectious DiseaseRespiratory
Generics

Lupin is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Respiratory. Key products include LAMIVUDINE AND ZIDOVUDINE.

1998
Since
230
Drugs
-
Trials
1967
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 33%
20 drugs
Infectious Disease 22%
13 drugs Phase 3: 1 Phase 1: 1
Respiratory 18%
10 drugs Phase 3: 2
Dermatology 16%
10 drugs
Oncology 10%
6 drugs Phase 1: 2

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...